We here extend these previous findings by showing that the inhibition of SR-BI prevents the uptake of LDL as well as HDL into patient-derived cultured ccRCC cells as well as into the 786-O and RCC4 cell lines (Figs. 6B, C; 7A, B). Here, SCARB1 is linked to nonpapillary renal cell carcinoma.